Nanoparticle therapy may help patients hospitalized with severe COVID-19 infections: Small clinical trial shows experimental OP-101 drug suppresses COVID-19-related inflammation and brain injury

Researchers say that an experimental dendrimer nanoparticle treatment called OP-101 substantially reduced the risk of death and need for a ventilator in a study of 24 severely ill adults hospitalized with COVID-19.